[Question] is 94.2% actually fine or am I being sold a rounding error
The claim in the title is exactly the claim I am making: is 94.2% actually fine or am I being sold a rounding error. Nothing implied beyond it.
Figures up front so nobody has to dig: 94.2%.
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
Sent the same vial to Janoshik and VendorInvestigate. 99.6% against a claimed 99.0%. The difference was the gradient, not the material.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
Did you run a blank between injections?
Did you run a blank between injections?
Agreed. And the corollary is that the method line on a certificate is not decoration, it is the number’s provenance.
Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.
Same method at both labs, or two different gradients?
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.
Can you post the trace with the axes labelled?
the column has a history and it shows in the peak shape
This. A shoulder that does not baseline-resolve is a question, not a quantity.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
integration decisions move the number more than the sample does
Same view — reporting the gradient is what makes a result checkable rather than merely stated.
a shoulder is not an impurity until you can resolve it
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
How old is the column and roughly how many injections has it seen?
What wavelength, and what was the gradient?
Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.
That is area percent, not mass percent. The trace cannot give you the second one.
LC-MS for identity, UV for relative quantity
Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
Yes. Retention time is a hypothesis about identity. Mass is the answer.
Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.
Right. And a blank between injections settles the carryover argument before it starts.
Agreed. Two analysts, one trace, two integration choices, and a spread that has nothing to do with the vial.
JEEP sent me the column, the gradient and the theoretical mass without being asked. That is a short list and they are on it.
- 1How old is the column and roughly how many injections has it seen?6 comments in this branch · started by u/freya_baptista